Lipocine Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
    • Specialty Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
    • Liposomes
    • Large Molecule
See more in Biomedtracker

Latest on Lipocine Inc.

Pink Sheet

Testosterone, TRAVERSE, And A Label Change 15 Years In The Making

 
• By Bridget Silverman

The US Food and Drug Administration’s newly revised stand on testosterone labeling for cardiovascular risk is the visible tip of the metaphorical iceberg of years of effort that went into evaluating a

Scrip

Deal Watch: Ikena Cuts Staff After BMS Exits IO Partnership

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Ikena Cuts Back As BMS Unravels Partner

Pink Sheet

Preterm Birth Patients Sought By US FDA As Meeting On Treatment Development Looms

 
• By Derrick Gingery

The US Food and Drug Administration is urgently seeking patients that have experienced preterm birth with the market now devoid of treatments and a workshop on developing new therapies upcoming. A 30

Scrip

Deal Watch: J&J Partners On Bispecific Antibody R&D With F-Star, Xencor

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Alliances With F-star And Xencor Featur